SNX30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.301970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.216000E-01
Normal-vs-Stage2
1.080010E-01
Normal-vs-Stage3
5.803800E-02
Normal-vs-Stage4
7.131000E-01
Stage1-vs-Stage2
9.343200E-01
Stage1-vs-Stage3
2.289800E-01
Stage1-vs-Stage4
4.191200E-01
Stage2-vs-Stage3
1.804210E-01
Stage2-vs-Stage4
2.740600E-01
Stage3-vs-Stage4
1.211770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.236800E-01
Normal-vs-AfricanAmerican
8.010200E-01
Normal-vs-Asian
4.616400E-02
Caucasian-vs-AfricanAmerican
1.096150E-01
Caucasian-vs-Asian
1.648800E-01
AfricanAmerican-vs-Asian
4.542300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.474400E-01
Normal-vs-Female
1.286620E-01
Male-vs-Female
8.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.840400E-01
Normal-vs-Age(41-60Yrs)
4.202600E-01
Normal-vs-Age(61-80Yrs)
6.003700E-02
Normal-vs-Age(81-100Yrs)
4.148300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.499400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.568000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.982200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.680700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.463900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.441800E-02
Normal-vs-Daily Drinker
3.805800E-02
Normal-vs-Weekly Drinker
7.022500E-02
Normal-vs-Occasional Drinker
1.106960E-01
Normal-vs-Social Drinker
5.543600E-01
Non Drinker-vs-Daily Drinker
8.367000E-01
Non Drinker-vs-Weekly Drinker
9.016200E-01
Non Drinker-vs-Occasional Drinker
6.175800E-01
Non Drinker-vs-Social Drinker
1.084200E-01
Daily Drinker-vs-Weekly Drinker
7.460600E-01
Daily Drinker-vs-Occasional Drinker
4.743600E-01
Daily Drinker-vs-Social Drinker
1.228180E-01
Weekly Drinker-vs-Occasional Drinker
7.323800E-01
Weekly Drinker-vs-Social Drinker
2.053800E-01
Occasional Drinker-vs-Social Drinker
2.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.690000E-01
Normal-vs-Grade 2
8.886600E-01
Normal-vs-Grade 3
8.830200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.264400E-01
Grade 1-vs-Grade 3
5.396400E-01
Grade 1-vs-Grade 4
8.690000E-01
Grade 2-vs-Grade 3
9.263200E-01
Grade 2-vs-Grade 4
8.886600E-01
Grade 3-vs-Grade 4
8.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.037900E-02
Normal-vs-NonDiabetic
1.306050E-01
Diabetic-vs-NonDiabetic
4.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.759900E-02
Normal-vs-NoPancreatitis
1.358230E-01
Pancreatitis-vs-NoPancreatitis
2.366200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.026600E-01
Normal-vs-N1
1.218600E-01
N0-vs-N1
7.921400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.287970E-01
Normal-vs-TP53-NonMutant
3.261000E-01
TP53-Mutant-vs-TP53-NonMutant
1.831040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
